Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Necchi

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
NPJ Vaccines|March 8, 2024
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccineValentino Conti, Omar Rossi, Kristen A Clarkson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2020
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM<sub>197</sub> conjugate vaccineFrancesca Micoli, Stefania P Bjarnarson, Melissa Arcuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2012
Identification of a common immune signature in murine and human systemic SalmonellosisSeung-Joo Lee, Li Liang, Silvia Juarez, et al.
NPJ Vaccines|September 5, 2023
A next-generation GMMA-based vaccine candidate to fight shigellosisOmar Rossi, Francesco Citiulo, Carlo Giannelli, et al.
Frontiers in Immunology|June 18, 2026
Development of a GMMA-based candidate vaccine against invasive nontyphoidal <i>Salmonella</i> diseaseFrancesco Citiulo, Oliver Koeberling, Omar Rossi, et al.
Mbio|March 8, 2018
IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <i>Salmonella</i> Develop at Discordant RatesAnna E Schager, C Coral Dominguez-Medina, Francesca Necchi, et al.
Eclinicalmedicine|August 25, 2021
Efficacy, safety, and immunogenicity of the <i>Shigella sonnei</i> 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adultsRobert W Frenck, Valentino Conti, Pietro Ferruzzi, et al.
Frontiers in Immunology|February 16, 2024
Age-dependent acquisition of IgG antibodies to <i>Shigella</i> serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccinationMelissa C Kapulu, Esther Muthumbi, Edward Otieno, et al.
The Journal of Infectious Diseases|June 10, 2024
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 StudyIsabel Leroux-Roels, Cathy Maes, Francesca Mancini, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2025
A multifunctional anti-O-Antigen human monoclonal antibody protects against <i>Shigella sonnei</i> infection in vivoMatteo Ridelfi, Giacomo Vezzani, Emanuele Roscioli, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
NPJ Vaccines|March 8, 2024
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccineValentino Conti, Omar Rossi, Kristen A Clarkson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2020
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM<sub>197</sub> conjugate vaccineFrancesca Micoli, Stefania P Bjarnarson, Melissa Arcuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2012
Identification of a common immune signature in murine and human systemic SalmonellosisSeung-Joo Lee, Li Liang, Silvia Juarez, et al.
NPJ Vaccines|September 5, 2023
A next-generation GMMA-based vaccine candidate to fight shigellosisOmar Rossi, Francesco Citiulo, Carlo Giannelli, et al.
Frontiers in Immunology|June 18, 2026
Development of a GMMA-based candidate vaccine against invasive nontyphoidal <i>Salmonella</i> diseaseFrancesco Citiulo, Oliver Koeberling, Omar Rossi, et al.
Mbio|March 8, 2018
IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <i>Salmonella</i> Develop at Discordant RatesAnna E Schager, C Coral Dominguez-Medina, Francesca Necchi, et al.
Eclinicalmedicine|August 25, 2021
Efficacy, safety, and immunogenicity of the <i>Shigella sonnei</i> 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adultsRobert W Frenck, Valentino Conti, Pietro Ferruzzi, et al.
Frontiers in Immunology|February 16, 2024
Age-dependent acquisition of IgG antibodies to <i>Shigella</i> serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccinationMelissa C Kapulu, Esther Muthumbi, Edward Otieno, et al.
The Journal of Infectious Diseases|June 10, 2024
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 StudyIsabel Leroux-Roels, Cathy Maes, Francesca Mancini, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2025
A multifunctional anti-O-Antigen human monoclonal antibody protects against <i>Shigella sonnei</i> infection in vivoMatteo Ridelfi, Giacomo Vezzani, Emanuele Roscioli, et al.
Pageof 5